Search alternatives:
026 decrease » _ decrease (Expand Search), a decrease (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
μ decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
50 μ » 10 μ (Expand Search), 5 μ (Expand Search)
5 non » _ non (Expand Search), a non (Expand Search), e non (Expand Search)
026 decrease » _ decrease (Expand Search), a decrease (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
μ decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
50 μ » 10 μ (Expand Search), 5 μ (Expand Search)
5 non » _ non (Expand Search), a non (Expand Search), e non (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
The decrease or inhibition of Hsp90 induced REST degradation.
Published 2019“…(D) The level of REST dramatically reduced in differentiated SH-SY5Y cells treated with GA (1 μM) or PU-H71 (50 nM) at 24 h. …”
-
10
-
11
Image_2_Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease.JPEG
Published 2019“…At the cutoff value of 7.955 μg/mL serum ZAG, the sensitivity and specificity for differentiating patients with PCAD from controls were 50.5 and 78.0%, respectively. …”
-
12
Image_1_Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease.JPEG
Published 2019“…At the cutoff value of 7.955 μg/mL serum ZAG, the sensitivity and specificity for differentiating patients with PCAD from controls were 50.5 and 78.0%, respectively. …”
-
13
Table_1_Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease.DOCX
Published 2019“…At the cutoff value of 7.955 μg/mL serum ZAG, the sensitivity and specificity for differentiating patients with PCAD from controls were 50.5 and 78.0%, respectively. …”
-
14
-
15
-
16
-
17
-
18
-
19
Shiga toxin expression in O157 following treatment with hGRNL, bNK2A, and pNKL peptides.
Published 2023Subjects: -
20
Hemolytic activities of hGRNL, bNK2A, and pNKL peptides on cattle red blood cells (RBCs).
Published 2023Subjects: